• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ras癌基因p21在肝细胞癌中的表达

ras oncogene p21 expression in hepatocellular carcinoma.

作者信息

Jagirdar J, Nonomura A, Patil J, Thor A, Paronetto F

机构信息

Immunopathology Laboratory, Veterans Administration Medical Center, Bronx, NY.

出版信息

J Exp Pathol. 1989;4(1):37-46.

PMID:2550600
Abstract

Aberrant proto-oncogene expression has been implicated in hepatic cell proliferation, transformation and carcinogenesis using a rat model. To investigate the role of ras p21 product expression in human hepatocellular carcinoma (HCC), we have localized ras p21 in formalin fixed, paraffin-embedded normal and abnormal livers utilizing the avidin-biotin peroxidase method and a monoclonal antibody to ras-gene product p21. A semi-quantitative estimate of p21 expression was performed by serial dilutions of primary antibody. While low dilutions of anti-p21 stained normal hepatocytes, higher dilutions failed to react with normal hepatocytes and these dilutions were used for assessment of p21 enhancement. Increased p21 expression of ras oncogene in HCC occurs in fibrolamellar carcinomas and other better differentiated HCC. Tumor dedifferentiation is associated with an attenuation of p21 expression. Liver adjacent to HCC exhibits p21 enhancement, in contrast to liver surrounding metastatic carcinoma, suggesting increased p21 expression in HCC induction.

摘要

利用大鼠模型已表明异常原癌基因表达与肝细胞增殖、转化及致癌作用有关。为了研究ras p21产物表达在人类肝细胞癌(HCC)中的作用,我们采用抗生物素蛋白-生物素过氧化物酶法及针对ras基因产物p21的单克隆抗体,对福尔马林固定、石蜡包埋的正常及异常肝脏中的ras p21进行了定位。通过对一抗进行系列稀释对p21表达进行半定量评估。低稀释度的抗p21可对正常肝细胞染色,而高稀释度则不能与正常肝细胞反应,这些高稀释度用于评估p21增强情况。HCC中ras癌基因的p21表达增加见于纤维板层癌及其他分化较好的HCC。肿瘤去分化与p21表达减弱有关。与转移性癌周围的肝脏相反,HCC邻近的肝脏呈现p21增强,提示HCC诱导过程中p21表达增加。

相似文献

1
ras oncogene p21 expression in hepatocellular carcinoma.Ras癌基因p21在肝细胞癌中的表达
J Exp Pathol. 1989;4(1):37-46.
2
The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors.c-myc和c-N-ras在人类肝硬化肝脏、肝细胞癌及肿瘤周围肝组织中的表达。
Oncogene. 1990 Jun;5(6):909-14.
3
Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.ras和myc癌基因在人肝细胞癌及非肿瘤性肝组织中的表达。
Anticancer Res. 1989 May-Jun;9(3):715-21.
4
Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.免疫组织化学法检测肝硬化及肝细胞癌中ras癌基因p21产物
Am J Gastroenterol. 1987 Jun;82(6):512-8.
5
Immunocytochemical localization of p21 ras gene product in human hepatoma cell lines and corresponding tumors in athymic mice.
J Exp Pathol. 1987;3(3):305-15.
6
[Comparative study of expression of p21 and c-myc protein in hepatocellular carcinoma with pericarcinomatous liver tissue].[肝细胞癌及癌旁肝组织中p21和c-myc蛋白表达的对比研究]
Hunan Yi Ke Da Xue Xue Bao. 1997;22(4):310-2.
7
[Expression of ras oncogene p21 product and proliferating cell nuclear antigen in liver cirrhosis and the correlation with liver cell dysplasia].[ras癌基因p21产物及增殖细胞核抗原在肝硬化中的表达及其与肝细胞发育异常的相关性]
Zhonghua Gan Zang Bing Za Zhi. 2000 Dec;8(6):343-5.
8
The expression of P21 and P15 proteins in liver tissue of chronic viral hepatitis and hepatocellular carcinoma and their relation to cell apoptosis.P21和P15蛋白在慢性病毒性肝炎及肝细胞癌肝组织中的表达及其与细胞凋亡的关系。
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2000 Jun;14(2):157-9.
9
In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.小鼠肝脏和人肝细胞癌中Kruppel样因子6肿瘤抑制基因对p21的体内调控
Oncogene. 2007 Jun 28;26(30):4428-34. doi: 10.1038/sj.onc.1210223. Epub 2007 Feb 5.
10
Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.ras和c-myc癌蛋白以及乙型肝炎表面抗原在人类肝脏疾病中的表达
Hepatogastroenterology. 1993 Feb;40(1):37-40.

引用本文的文献

1
Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis.探讨肝细胞癌中非编码 RNA 机制:对治疗和预后的影响。
Front Immunol. 2024 May 10;15:1400744. doi: 10.3389/fimmu.2024.1400744. eCollection 2024.
2
Effects of endotoxin on expression of ras, p53 and bcl-2 oncoprotein in hepatocarcinogenesis induced by thioacetamide in rats.内毒素对硫代乙酰胺诱导的大鼠肝癌发生过程中ras、p53和bcl-2癌蛋白表达的影响。
World J Gastroenterol. 1997 Dec 15;3(4):213-7. doi: 10.3748/wjg.v3.i4.213.
3
New insights in hepatocellular carcinoma: from bench to bedside.
肝细胞癌的新见解:从基础到临床。
Ann Transl Med. 2013 Jul;1(2):15. doi: 10.3978/j.issn.2305-5839.2013.01.06.
4
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.肝癌中的微小RNA:一种用于研究发病机制和新型治疗方法的模型
Cell Death Differ. 2015 Jan;22(1):46-57. doi: 10.1038/cdd.2014.136. Epub 2014 Sep 5.
5
Allosteric MEK1/2 inhibitor refametinib (BAY 86-9766) in combination with sorafenib exhibits antitumor activity in preclinical murine and rat models of hepatocellular carcinoma.变构MEK1/2抑制剂瑞法美替尼(BAY 86-9766)与索拉非尼联合使用,在肝细胞癌的临床前小鼠和大鼠模型中显示出抗肿瘤活性。
Neoplasia. 2013 Oct;15(10):1161-71. doi: 10.1593/neo.13812.
6
Decreased apoptosis in advanced-stage/high-grade hepatocellular carcinoma complicating chronic hepatitis C is mediated through the downregulation of p21 ras.慢性丙型肝炎并发晚期/高级别肝细胞癌中凋亡减少是通过下调 p21 ras 介导的。
Chin J Cancer Res. 2013 Jun;25(3):281-8. doi: 10.3978/j.issn.1000-9604.2013.04.02.
7
Molecular mechanisms underlying hepatocellular carcinoma.肝细胞癌的分子机制。
Viruses. 2009 Dec;1(3):852-72. doi: 10.3390/v1030852. Epub 2009 Nov 9.
8
MicroRNA involvement in hepatocellular carcinoma.微小RNA与肝细胞癌的关系
J Cell Mol Med. 2008 Dec;12(6A):2189-204. doi: 10.1111/j.1582-4934.2008.00533.x.
9
Genetics of hepatocellular carcinoma.肝细胞癌的遗传学
World J Gastroenterol. 2007 Apr 28;13(16):2271-82. doi: 10.3748/wjg.v13.i16.2271.